Therapeutic regulation of gene expression in the inner ear using RNA interference.
Targeting and downregulating specific genes with antisense and decoy oligonucleotides, ribozymes or RNA interference (RNAi) offer the theoretical potential of altering a disease phenotype. Here we review the molecular mechanism behind the in vivo application of RNAi-mediated gene silencing, focusing on its application to the inner ear. RNAi is a physiological phenomenon in which small, double-stranded RNA molecules (small interfering RNA, siRNA) reduce expression of homologous genes. Notable for its exquisite sequence specificity, it is ideally applied to diseases caused by a gain-of-function mechanism of action. Types of deafness in which gain-of-function mutations are observed include DFNA2 (KCNQ4), DFNA3 (GJB2) and DFNA5 (DFNA5). Several strategies can be used to deliver siRNA into the inner ear, including cationic liposomes, adeno-associated and lentiviral vectors, and adenoviral vectors. Transduction efficiency with cationic liposomes is low and the effect is transient; with adeno-associated and lentiviral vectors, long-term transfection is possible using a small hairpin RNA expression cassette.
Maeda
Yukihide
Y
Sheffield
Abraham M
AM
Smith
Richard J H
RJH
D000818:Animals; D003052:Cochlear Aqueduct / Q000502:physiology; D000072259:Connexin 26; D017630:Connexins; D005786:Gene Expression Regulation / Q000502:physiology; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006319:Hearing Loss, Sensorineural / Q000235:genetics; D006801:Humans; D051656:KCNQ Potassium Channels / Q000235:genetics; D007759:Labyrinth Diseases / Q000628:therapy*; D020320:Oligoribonucleotides, Antisense / Q000502:physiology; D034622:RNA Interference / Q000502:physiology; D016337:RNA, Catalytic / Q000502:physiology; D014162:Transfection
D017630:Connexins; C000607042:GJB2 protein, human; D051656:KCNQ Potassium Channels; C117367:KCNQ4 protein, human; D020320:Oligoribonucleotides, Antisense; D016337:RNA, Catalytic; C427204:hammerhead ribozyme; D000072259:Connexin 26